TY - JOUR
T1 - Management of Small Renal Masses
AU - Kunkle, David A.
AU - Kutikov, Alexander
AU - Uzzo, Robert G.
PY - 2009/8
Y1 - 2009/8
N2 - Surgical excision of renal cell carcinoma is the current standard of care for localized disease. Series for small renal masses treated with surgery demonstrate excellent oncologic outcomes with 5-year survival rates over 95%. Minimally invasive ablative technologies, such as cryotherapy and radiofrequency ablation, have recently emerged with similar short- and intermediate-term results. Additionally, recent data on active surveillance have demonstrated survival rates comparable to surgery and ablation in selected patient populations. We review the currently available data regarding the management of small renal masses by excision, ablation, or observation.
AB - Surgical excision of renal cell carcinoma is the current standard of care for localized disease. Series for small renal masses treated with surgery demonstrate excellent oncologic outcomes with 5-year survival rates over 95%. Minimally invasive ablative technologies, such as cryotherapy and radiofrequency ablation, have recently emerged with similar short- and intermediate-term results. Additionally, recent data on active surveillance have demonstrated survival rates comparable to surgery and ablation in selected patient populations. We review the currently available data regarding the management of small renal masses by excision, ablation, or observation.
UR - http://www.scopus.com/inward/record.url?scp=67649890628&partnerID=8YFLogxK
U2 - 10.1053/j.sult.2009.03.002
DO - 10.1053/j.sult.2009.03.002
M3 - Article
C2 - 19711645
SN - 0887-2171
VL - 30
SP - 352
EP - 358
JO - Seminars in Ultrasound, CT and MRI
JF - Seminars in Ultrasound, CT and MRI
IS - 4
ER -